Scoop: Rakuten bil­lion­aire lines up $70M for pho­toim­munother­a­py

E-com­merce bil­lion­aire Hi­roshi “Mick­ey” Mik­i­tani has lined up an­oth­er $70 mil­lion for his pho­toim­munother­a­py biotech, a Rakuten Med­ical spokesper­son con­firmed to End­points News in an email.

The Japan­ese and US biotech, which went un­der the name As­pyr­i­an Ther­a­peu­tics un­til a few years ago, has lined up that amount in debt and se­cu­ri­ties that can be ac­quired, ac­cord­ing to an SEC fil­ing from the last week of 2022. The spokesper­son said the round was a con­vert­ible note.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER